✦ LIBER ✦

Impact of drug shortages on cancer care: The story of pegylated liposomal doxorubicin in ovarian cancer

✍ Scribed by A. Goodman; L. Sullivan; K. Lafleur; R. Penson; J. Schorge; M. Del Carmen; D. Boruta; W. Growdon; C. Krasner; M. Birrer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated liposomal doxorubicin promisin

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Role of pegylated liposomal doxorubicin

✍ J. Tate Thigpen; Carol A. Aghajanian; David S. Alberts; Susana M. Campos; Alan N 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Pharmacological basis of pegylated lipos

✍ Alberto Gabizon; Hilary Shmeeda; Tal Grenader 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 952 KB

Phase II study of pegylated liposomal do

✍ M.O. Nicoletto; C. Falci; D. Pianalto; G. Artioli; P. Azzoni; G. De Masi; E. Fer 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 128 KB

A multicenter phase II study of pegylate

✍ Francesco Recchia; Gaetano Saggio; Giovanna Amiconi; Anna Di Blasio; Alisia Cest 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 235 KB

A retrospective analysis of pegylated li

✍ Nicoletta Staropoli, Domenico Ciliberto, Cirino Botta… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 189 KB